Investments (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
| Equity Method Investments and Joint Ventures [Abstract] |
|
| Schedule of Investments |
Investments consist of the following: | | | | | | | | | | | | | March 31, | | 2026 | | 2025 | | Equity method investments in Funds | $ | 567,888 | | | $ | 453,636 | | | Other equity method investments | — | | | 386 | | | Fair value investments | — | | | 12,190 | | | Measurement alternative investments | 206,555 | | | 198,142 | | | Total Investments | $ | 774,443 | | | $ | 664,354 | |
|
| Schedule of Variable Interest Entities |
Investments of Consolidated Funds and Partnerships consist of the following: | | | | | | | | | | | | | March 31, | | 2026 | | 2025 | | Equity method investments in Funds | $ | 20,841 | | | $ | 19,292 | | | Fair value investments | 505,237 | | | 77,408 | | | Total Investments of Consolidated Funds and Partnerships | $ | 526,078 | | | $ | 96,700 | |
The following table presents the assets and liabilities of consolidated VIEs that are included in the Consolidated Balance Sheets. | | | | | | | | | | | | | March 31, | | 2026 | | 2025 | | Assets of Consolidated Funds and Partnerships: | | | | | Cash and cash equivalents | $ | — | | | $ | 48,112 | | | Investments | 487,357 | | | 96,700 | | | Other assets | 9,516 | | | 460 | | | Total assets | $ | 496,873 | | | $ | 145,272 | | | | | | | Liabilities of Consolidated Funds and Partnerships: | | | | | Subscriptions in advance | $ | 55,561 | | | $ | — | | | Other liabilities | 12,902 | | | 922 | | | Total liabilities | $ | 68,463 | | | $ | 922 | |
The carrying value of assets and liabilities recognized in the Consolidated Balance Sheets related to the Company’s interests in these non-consolidated VIEs and the Company’s maximum exposure to loss relating to non-consolidated VIEs were as follows: | | | | | | | | | | | | | March 31, | | 2026 | | 2025 | | Investments | $ | 284,958 | | | $ | 256,350 | | | Fees receivable | 43,607 | | | 48,601 | | | Due from related parties | 7,573 | | | 4,723 | | | Total VIE assets | 336,138 | | | 309,674 | | | Non-controlling interests | (2,190) | | | (2,497) | | | Maximum exposure to loss | $ | 333,948 | | | $ | 307,177 | |
|
| Schedule of Equity Method Investments |
The Company’s equity method investments in Funds consist of the following types: | | | | | | | | | | | | | March 31, | | 2026 | | 2025 | | Primary funds | $ | 39,972 | | | $ | 35,251 | | | Secondary funds | 70,601 | | | 60,545 | | | Direct investment funds | 100,116 | | | 94,257 | | | Customized separate accounts | 163,090 | | | 141,088 | | | Evergreen funds | 194,109 | | | 122,495 | | | Total equity method investments in Funds | $ | 567,888 | | | $ | 453,636 | |
The summarized financial information of the Company’s equity method investments in Funds is as follows: | | | | | | | | | | | | | | | | | | | March 31, | | | | 2026 | | 2025 | | | | Assets | | | | | | | Investments | $ | 59,976,551 | | | $ | 50,486,273 | | | | | Other assets | 2,231,251 | | | 1,242,238 | | | | | Total assets | $ | 62,207,802 | | | $ | 51,728,511 | | | | | Liabilities and Partners’ Capital | | | | | | | Debt | $ | 369,438 | | | $ | 494,430 | | | | | Other liabilities | 851,571 | | | 741,822 | | | | | Total liabilities | 1,221,009 | | | 1,236,252 | | | | | Partners’ capital | 60,986,792 | | | 50,492,259 | | | | | Total liabilities and partners’ capital | $ | 62,207,801 | | | $ | 51,728,511 | | | | | | | | | | | Year Ended March 31, | | 2026 | | 2025 | | 2024 | | Investment income | $ | 916,410 | | | $ | 870,828 | | | $ | 625,176 | | | Expenses | 531,670 | | | 487,339 | | | 403,517 | | | Net investment income | 384,740 | | | 383,489 | | | 221,659 | | | Net realized and unrealized gain | 4,470,303 | | | 1,690,743 | | | 2,672,499 | | | Net income | $ | 4,855,043 | | | $ | 2,074,232 | | | $ | 2,894,158 | |
|
| Schedule of Equity Securities without Readily Determinable Fair Value |
The following table summarizes the activity related to the Company’s measurement alternative investments: | | | | | | | | | | | | | | | | | | | Year Ended March 31, | | 2026 | | 2025 | | 2024 | | Carrying amount, beginning of the year | $ | 198,142 | | | $ | 175,522 | | | $ | 168,732 | | | Adjustments related to equity investments | | | | | | | Purchases | 8,000 | | | 13,853 | | | 6,311 | | | Sales / return of capital | — | | | — | | | (176) | | Net change in unrealized gain (loss)1 | 413 | | | 8,767 | | | 1,177 | | | Net realized loss | — | | | — | | | (522) | | | | | | | | | Carrying amount, end of year | $ | 206,555 | | | $ | 198,142 | | | $ | 175,522 | |
(1) Net change in unrealized gain (loss) consists of fair value adjustments for observable price changes of identical or similar investments.
|
| Schedule of Cumulative Gross Unrealized Gains(Loss) |
The following table summarizes the cumulative gross unrealized gains and cumulative gross unrealized losses related to the Company’s measurement alternative investments: | | | | | | | | | | | | | | | | | | | As of March 31, | | 2026 | | 2025 | | 2024 | | Cumulative gross unrealized gains | $ | 79,414 | | | $ | 79,002 | | | $ | 70,235 | | | Cumulative gross unrealized losses | $ | (43,289) | | | $ | (43,289) | | | $ | (43,289) | |
|